Market closedNon-fractional
iRhythm/IRTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About iRhythm
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Ticker
IRTC
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
San Francisco, United States
Employees
2,000
Website
www.irhythmtech.com
iRhythm Metrics
BasicAdvanced
$3B
Market cap
-
P/E ratio
-$4.23
EPS
1.24
Beta
-
Dividend rate
Price and volume
Market cap
$3B
Beta
1.24
Financial strength
Current ratio
7.099
Quick ratio
6.803
Long term debt to equity
799.331
Total debt to equity
816.264
Interest coverage (TTM)
-17.42%
Management effectiveness
Return on assets (TTM)
-9.09%
Return on equity (TTM)
-83.28%
Valuation
Price to revenue (TTM)
5.681
Price to book
32.81
Price to tangible book (TTM)
33.12
Price to free cash flow (TTM)
-25.766
Growth
Revenue change (TTM)
19.35%
Earnings per share change (TTM)
21.67%
3-year revenue growth (CAGR)
22.97%
3-year earnings per share growth (CAGR)
24.23%
What the Analysts think about iRhythm
Analyst Ratings
Majority rating from 12 analysts.
iRhythm Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$132M
-0.45%
Net income
-$46M
18.13%
Profit margin
-34.57%
18.67%
iRhythm Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.61
-$0.89
-$1.26
-$1.23
-
Expected
-$0.77
-$0.64
-$0.59
-$0.96
-$0.89
Surprise
-21.01%
39.09%
112.72%
28.10%
-
iRhythm News
AllArticlesVideos
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
GlobeNewsWire·1 week ago
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
GlobeNewsWire·1 month ago
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for iRhythm stock?
iRhythm (IRTC) has a market cap of $3B as of July 27, 2024.
What is the P/E ratio for iRhythm stock?
The price to earnings (P/E) ratio for iRhythm (IRTC) stock is 0 as of July 27, 2024.
Does iRhythm stock pay dividends?
No, iRhythm (IRTC) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next iRhythm dividend payment date?
iRhythm (IRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for iRhythm?
iRhythm (IRTC) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell iRhythm stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.